DaVita HealthCare Partners Company Profile (NYSE:DVA)

About DaVita HealthCare Partners (NYSE:DVA)

DaVita HealthCare Partners logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:DVA
  • CUSIP: 23918K10
  • Web: www.davita.com
  • Market Cap: $10.88 billion
  • Outstanding Shares: 191,199,000
Average Prices:
  • 50 Day Moving Avg: $58.31
  • 200 Day Moving Avg: $62.84
  • 52 Week Range: $53.58 - $70.16
  • Trailing P/E Ratio: 8.67
  • Foreward P/E Ratio: 15.02
  • P/E Growth: 1.22
Sales & Book Value:
  • Annual Revenue: $15.01 billion
  • Price / Sales: 0.73
  • Book Value: $26.59 per share
  • Price / Book: 2.14
  • EBITDA: $2.45 billion
  • Net Margins: 8.68%
  • Return on Equity: 14.02%
  • Return on Assets: 3.78%
  • Debt-to-Equity Ratio: 1.69%
  • Current Ratio: 1.45%
  • Quick Ratio: 1.38%
  • Average Volume: 1.80 million shs.
  • Beta: 0.9
  • Short Ratio: 4.52

Frequently Asked Questions for DaVita HealthCare Partners (NYSE:DVA)

What is DaVita HealthCare Partners' stock symbol?

DaVita HealthCare Partners trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How will DaVita HealthCare Partners' stock buyback program work?

DaVita HealthCare Partners declared that its board has authorized a share repurchase program on Wednesday, October 11th 2017, which allows the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company's management believes its shares are undervalued.

How were DaVita HealthCare Partners' earnings last quarter?

DaVita HealthCare Partners Inc. (NYSE:DVA) posted its quarterly earnings results on Tuesday, August, 1st. The company reported $0.92 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.90 by $0.02. The company earned $3.88 billion during the quarter, compared to analysts' expectations of $3.82 billion. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The company's revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.01 earnings per share. View DaVita HealthCare Partners' Earnings History.

When will DaVita HealthCare Partners make its next earnings announcement?

DaVita HealthCare Partners is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for DaVita HealthCare Partners.

Where is DaVita HealthCare Partners' stock going? Where will DaVita HealthCare Partners' stock price be in 2017?

9 analysts have issued twelve-month target prices for DaVita HealthCare Partners' stock. Their predictions range from $57.00 to $70.00. On average, they expect DaVita HealthCare Partners' share price to reach $65.00 in the next year. View Analyst Ratings for DaVita HealthCare Partners.

Who are some of DaVita HealthCare Partners' key competitors?

Who are DaVita HealthCare Partners' key executives?

DaVita HealthCare Partners' management team includes the folowing people:

  • Kent J. Thiry, Chairman of the Board
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer
  • Joel Ackerman, Chief Financial Officer
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care
  • Jeanine M. Jiganti, Chief Compliance Officer
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs
  • Michael D. Staffieri, Chief Operating Officer- Kidney Care
  • Kathleen Alyce Waters, Chief Legal Officer
  • Peter T. Grauer, Lead Director, Independent Director

Who owns DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock is owned by a number of of retail and institutional investors. Top institutional investors include Eqis Capital Management Inc. (0.00%). Company insiders that own DaVita HealthCare Partners stock include Charles Berg, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Laura Mildenberger, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Roger Valine and William L Roper. View Institutional Ownership Trends for DaVita HealthCare Partners.

Who bought DaVita HealthCare Partners stock? Who is buying DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was bought by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for DaVita HealthCare Partners.

How do I buy DaVita HealthCare Partners stock?

Shares of DaVita HealthCare Partners can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DaVita HealthCare Partners' stock price today?

One share of DaVita HealthCare Partners stock can currently be purchased for approximately $56.93.

MarketBeat Community Rating for DaVita HealthCare Partners (NYSE DVA)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  279 (Vote Outperform)
Underperform Votes:  291 (Vote Underperform)
Total Votes:  570
MarketBeat's community ratings are surveys of what our community members think about DaVita HealthCare Partners and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for DaVita HealthCare Partners (NYSE:DVA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 6 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.89)
Consensus Price Target: $65.00 (14.18% upside)
Consensus Price Target History for DaVita HealthCare Partners (NYSE:DVA)
Price Target History for DaVita HealthCare Partners (NYSE:DVA)
Analysts' Ratings History for DaVita HealthCare Partners (NYSE:DVA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/15/2017SunTrust Banks, Inc.Set Price TargetHold$57.00N/AView Rating Details
10/10/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/9/2017J P Morgan Chase & CoDowngradeNeutral -> UnderweightN/AView Rating Details
9/6/2017Royal Bank Of CanadaReiterated RatingHold$64.00LowView Rating Details
8/3/2017Jefferies Group LLCReiterated RatingHold$70.00MediumView Rating Details
5/25/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSell$62.00HighView Rating Details
12/13/2016Robert W. BairdDowngradeOutperform -> Neutral$68.00 -> $69.00N/AView Rating Details
11/21/2016Bank of America CorpReiterated RatingHold$68.00N/AView Rating Details
11/1/2016Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
9/20/2016Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$75.00N/AView Rating Details
9/6/2016Citigroup Inc.Initiated CoverageNeutral$71.00N/AView Rating Details
4/6/2016Susquehanna Bancshares IncBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
2/12/2016William BlairReiterated RatingBuyN/AView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00N/AView Rating Details
(Data available from 10/16/2015 forward)


Earnings History for DaVita HealthCare Partners (NYSE:DVA)
Earnings by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Earnings History by Quarter for DaVita HealthCare Partners (NYSE DVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$0.94N/AView Earnings Details
8/1/2017Q2 2017$0.90$0.92$3.82 billion$3.88 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for DaVita HealthCare Partners (NYSE:DVA)
2017 EPS Consensus Estimate: $3.55
2018 EPS Consensus Estimate: $3.82
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.77$0.84$0.81
Q2 20173$0.90$0.92$0.91
Q3 20173$0.90$0.95$0.93
Q4 20173$0.90$0.91$0.91
Q1 20182$0.85$0.85$0.85
Q2 20182$0.97$0.99$0.98
Q3 20182$0.99$1.03$1.01
Q4 20182$0.97$0.99$0.98
Q1 20191$0.92$0.92$0.92
Q2 20191$1.08$1.08$1.08
(Data provided by Zacks Investment Research)


Dividend History for DaVita HealthCare Partners (NYSE:DVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for DaVita HealthCare Partners (NYSE:DVA)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 83.23%
Insider Trades by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Insider Trades by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.74View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.20View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.66View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.58View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.41View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.00View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.84View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.64View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.20View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.00View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.04View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.97View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.04View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.46View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.80View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.00View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.84View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.60View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.00View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10View SEC Filing  
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.60View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.76View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.00View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.18View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.00View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.28View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.68View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.05View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.96View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.26View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.00View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.03View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.01View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.07View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.16View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for DaVita HealthCare Partners (NYSE:DVA)
Latest Headlines for DaVita HealthCare Partners (NYSE:DVA)
finance.yahoo.com logoDaVita Provides Additional Information Regarding Patients Receiving Charitable Premium Assistance
finance.yahoo.com - October 16 at 6:46 PM
finance.yahoo.com logoDaVita Inc. Schedules 3rd Quarter 2017 Investor Conference Call
finance.yahoo.com - October 16 at 6:46 PM
finance.yahoo.com logoDaVita estimates charitable assistance loss would total up to $250M
finance.yahoo.com - October 16 at 6:46 PM
finance.yahoo.com logoThe Hot Stock: DaVita Surges
finance.yahoo.com - October 16 at 6:46 PM
americanbankingnews.com logoHead to Head Analysis: DaVita HealthCare Partners (DVA) and Its Peers
www.americanbankingnews.com - October 15 at 4:28 AM
finance.yahoo.com logoETFs with exposure to DaVita, Inc. : October 13, 2017
finance.yahoo.com - October 13 at 6:37 PM
americanbankingnews.com logoFY2019 EPS Estimates for DaVita HealthCare Partners Inc. Decreased by Analyst (DVA)
www.americanbankingnews.com - October 13 at 3:26 PM
americanbankingnews.com logoReviewing DaVita HealthCare Partners (DVA) and Select Medical Holdings Corporation (SEM)
www.americanbankingnews.com - October 12 at 8:34 PM
finanznachrichten.de logoPro-Trader Daily: Corporate News Blog - DaVita Divulges Information Regarding Charitable Premium Assistance
www.finanznachrichten.de - October 12 at 6:52 PM
finance.yahoo.com logoDaVita Announced as New Partner for The Denver Post Season to Share
finance.yahoo.com - October 12 at 6:52 PM
finance.yahoo.com logoCorporate News Blog - DaVita Divulges Information Regarding Charitable Premium Assistance
finance.yahoo.com - October 12 at 6:52 PM
americanbankingnews.com logoKeyCorp Comments on DaVita HealthCare Partners Inc.'s FY2018 Earnings (DVA)
www.americanbankingnews.com - October 12 at 1:54 PM
americanbankingnews.com logoZacks Investment Research Lowers DaVita HealthCare Partners Inc. (DVA) to Sell
www.americanbankingnews.com - October 11 at 3:22 PM
americanbankingnews.com logoDaVita HealthCare Partners (DVA) to Buyback $1.50 billion in Shares
www.americanbankingnews.com - October 11 at 11:08 AM
americanbankingnews.com logoComparing DaVita HealthCare Partners (DVA) & Air Methods Corp (AIRM)
www.americanbankingnews.com - October 11 at 2:10 AM
finance.yahoo.com logoRite Aid, Walgreens Once Again Dip into Tuesday’s 52-Week Low Club
finance.yahoo.com - October 10 at 8:49 PM
nasdaq.com logoDaVita Banks on Acquisitions, Escalating Expenses a Concern - Nasdaq
www.nasdaq.com - October 10 at 3:49 PM
finance.yahoo.com logoDaVita Provides Disclosures Regarding Charitable Premium Assistance
finance.yahoo.com - October 10 at 3:48 PM
finance.yahoo.com logoDaVita VillageHealth Receives Disease Management Recertification
finance.yahoo.com - October 10 at 3:48 PM
finance.yahoo.com logoDowngrade, stock slide prompts DaVita kidney-fund response
finance.yahoo.com - October 10 at 3:48 PM
finance.yahoo.com logoMore Than 18,000 Technicians Contribute to Life-Saving Care
finance.yahoo.com - October 9 at 6:25 PM
finance.yahoo.com logoJP Morgan: Hasta DaVita!
finance.yahoo.com - October 9 at 6:25 PM
finance.yahoo.com logoWhy DaVita Inc. Sank Lower Today
finance.yahoo.com - October 9 at 6:25 PM
finance.yahoo.com logoWhy Viacom, DaVita, and K2M Group Holdings Slumped Today
finance.yahoo.com - October 9 at 6:24 PM
finance.yahoo.com logoThe Biggest Loser: DaVita Tumbles 9.9%
finance.yahoo.com - October 9 at 6:24 PM
finance.yahoo.com logoDaVita: Buffett's Next Acquisition?
finance.yahoo.com - October 3 at 9:33 AM
finance.yahoo.com logoShould Value Investors Consider DaVita Inc. (DVA) Stock?
finance.yahoo.com - October 3 at 9:33 AM
finance.yahoo.com logoDaVita, Inc. :DVA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 3 at 9:33 AM
finance.yahoo.com logoETFs with exposure to DaVita, Inc. : October 2, 2017
finance.yahoo.com - October 3 at 9:33 AM
finance.yahoo.com logoMore Than 600 Cyclists to Ride through Washington State in 11th Annual Tour DaVita
finance.yahoo.com - October 3 at 9:33 AM
americanbankingnews.com logoFinancial Comparison: Streamline Health Solutions (STRM) versus DaVita HealthCare Partners (DVA)
www.americanbankingnews.com - October 1 at 6:24 AM
americanbankingnews.com logoCritical Comparison: HealthSouth Corporation (HLS) vs. DaVita HealthCare Partners (DVA)
www.americanbankingnews.com - September 30 at 2:24 PM
americanbankingnews.com logoFinancial Comparison: DaVita HealthCare Partners (DVA) & Its Peers
www.americanbankingnews.com - September 29 at 6:24 PM
americanbankingnews.com logoNobilis Health Corp (HLTH) vs. DaVita HealthCare Partners (DVA) Head to Head Analysis
www.americanbankingnews.com - September 26 at 2:32 PM
americanbankingnews.com logoTraders Purchase Large Volume of Put Options on DaVita HealthCare Partners (DVA)
www.americanbankingnews.com - September 25 at 8:52 AM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - September 24 at 2:48 PM
finance.yahoo.com logoThe Biggest Loser: DaVita Dives
finance.yahoo.com - September 22 at 5:07 PM
finance.yahoo.com logoDaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : September 19, 2017
finance.yahoo.com - September 19 at 6:03 PM
nasdaq.com logoNovember 17th Options Now Available For DaVita (DVA)
www.nasdaq.com - September 18 at 5:53 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. to Post Q1 2019 Earnings of $0.92 Per Share, SunTrust Banks Forecasts (DVA)
www.americanbankingnews.com - September 18 at 8:00 AM
finance.yahoo.com logoDaVita's (DVA) Green Initiatives Win a Coveted Golden Reward
finance.yahoo.com - September 14 at 3:38 PM
americanbankingnews.com logo$3.83 Billion in Sales Expected for DaVita HealthCare Partners Inc. (DVA) This Quarter
www.americanbankingnews.com - September 14 at 1:54 AM
nasdaq.com logoDaVita HealthCare (DVA) Down 9.1% Since Earnings Report: Can It Rebound? - Nasdaq
www.nasdaq.com - September 11 at 6:38 PM
finance.yahoo.com logoDaVita HealthCare (DVA) Down 9.1% Since Earnings Report: Can It Rebound?
finance.yahoo.com - September 11 at 6:38 PM
finance.yahoo.com logoDaVita Kidney Care Celebrates its 18,000 Nephrology Nurses
finance.yahoo.com - September 11 at 6:38 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Earns Hold Rating from Royal Bank Of Canada
www.americanbankingnews.com - September 6 at 9:40 PM
finance.yahoo.com logoDaVita Inc. to Participate in RW Baird 2017 Global Healthcare Conference
finance.yahoo.com - September 1 at 6:24 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 30 at 5:06 PM
finance.yahoo.com logoDaVita Announces Veterans Hiring Initiative
finance.yahoo.com - August 24 at 7:00 PM
americanbankingnews.com logoDaVita HealthCare Partners (DVA) & Community Health Systems (CYH) Head-To-Head Survey
www.americanbankingnews.com - August 20 at 2:28 PM



DaVita HealthCare Partners (DVA) Chart for Monday, October, 16, 2017

This page was last updated on 10/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.